Literature DB >> 8495107

Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells.

P Yaswen1, M R Stampfer, K Ghosh, J S Cohen.   

Abstract

We have compared the effects of a number of different oligonucleotides on the growth and morphology of normal finite life span and immortally transformed human mammary epithelial cells. The oligonucleotide sequences chosen initially for study were based on that of the NB-1 gene, which encodes a calmodulin-like protein of unknown function. We found that certain thioated oligonucleotides 15-20 residues in length altered the morphology and decreased the growth rate of the normal cells in a concentration-dependent manner. These effects were rapid, occurring within 24-48 h of oligonucleotide addition. The effects, which occurred without an accompanying detectable decrease in the levels of NB-1 mRNA or protein, were most pronounced in the normal epithelial cells, less apparent in the immortalized epithelial cells, and unobserved in normal breast fibroblasts. Identical sequences having mixed phosphodiester and phosphorothioate backbones, or phosphodiester backbones alone, had little or no effect on normal epithelial cell morphology or growth. Two out of seven additional thioated oligonucleotides which were not complementary to NB-1 mRNA, also affected normal epithelial cell morphology and growth when used at similar concentrations (10 microM). Taken together, the observed effects on normal epithelial cells indicate that certain thioated oligonucleotides may have pharmacological consequences that do not depend on strict complementarity of their sequences to known mRNAs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8495107     DOI: 10.1089/ard.1993.3.67

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN: 1050-5261


  21 in total

Review 1.  Rescue of B cells from apoptosis by immune stimulatory CpG DNA.

Authors:  A M Krieg; A K Yi
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.

Authors:  Paula J Bates; Damian A Laber; Donald M Miller; Shelia D Thomas; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-20       Impact factor: 3.362

3.  Temperature and salt dependence of higher order structure formation by antisense c-myc and c-myb phosphorothioate oligodeoxyribonucleotides containing tetraguanylate tracts.

Authors:  S Basu; E Wickstrom
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

Review 4.  Antisense approaches to the gene therapy of cancer--'Recnac'.

Authors:  I Gibson
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

5.  Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo.

Authors:  T Skorski; D Perrotti; M Nieborowska-Skorska; S Gryaznov; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

6.  Design and characterization of decoy oligonucleotides containing locked nucleic acids.

Authors:  Rita Crinelli; Marzia Bianchi; Lucia Gentilini; Mauro Magnani
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

7.  Gene therapy for cancers.

Authors:  L Lashford
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

8.  Inhibition of HSV-1 proliferation by decoy phosphodiester oligonucleotides containing ICP4 recognition sequences.

Authors:  C Clusel; S Meguenni; I Elias; M Vasseur; M Blumenfeld
Journal:  Gene Expr       Date:  1995

9.  Prevention of tumor formation in a mouse model of Burkitt's lymphoma by 6 weeks of treatment with anti-c-myc DNA phosphorothioate.

Authors:  Y Huang; R Snyder; M Kligshteyn; E Wickstrom
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

10.  Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo.

Authors:  H Soreq; D Patinkin; E Lev-Lehman; M Grifman; D Ginzberg; F Eckstein; H Zakut
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.